Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats

In vivo treatment with an antisense (AS) phosphorothioate oligodeoxynucleotide (oligo) to the rat κ-opioid receptor selectively inhibited κ-mediated analgesia in the rat cold-water tail-flick test. Intracerebroventricular (i.c.v.) AS oligo significantly inhibited the analgesic effect of i.c.v. spira...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1994-12, Vol.667 (1), p.129-132
Hauptverfasser: Adams, Jill U., Chen, Xiaohong, DeRiel, J. Kim, Adler, Martin W., Liu-Chen, Lee-Yuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 132
container_issue 1
container_start_page 129
container_title Brain research
container_volume 667
creator Adams, Jill U.
Chen, Xiaohong
DeRiel, J. Kim
Adler, Martin W.
Liu-Chen, Lee-Yuan
description In vivo treatment with an antisense (AS) phosphorothioate oligodeoxynucleotide (oligo) to the rat κ-opioid receptor selectively inhibited κ-mediated analgesia in the rat cold-water tail-flick test. Intracerebroventricular (i.c.v.) AS oligo significantly inhibited the analgesic effect of i.c.v. spiradoline, but not that of μ- or δ-opioid agonists. The dose-effect curve for s.c. spiradoline was shifted to the right after AS, but not missense or sense oligo treatment. Thus, AS oligos provide another technique with which to selectively manipulate opioid receptors and further support the role of non-μ opioid receptors in mediating analgesia in rats.
doi_str_mv 10.1016/0006-8993(94)91723-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77802987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000689939491723X</els_id><sourcerecordid>77802987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-e627722dc7260b51422e036b90bd2ba787c0358b8380dcac28de0d21547e0a7e3</originalsourceid><addsrcrecordid>eNqFkc2KFDEQgIMo67j6Bgp9EFkPrfnp7iSXBVlWXVjworC3kE5qZkt6kjFJr-5L-EA-hM9k2hnmqBAIVfVVUdRHyHNG3zDKhreU0qFVWosz3b3WTHLR3jwgK6Ykbwfe0YdkdUQekyc5f62hEJqekBOpdE9lvyI_r0JJ1kGCMcU7qAG6ebKpKQls2dZE8x3LbWNDfQUzhAxNnHATPcQf92F2E8SCHpoSm9-_2rjDiL5J4GBXYsoNhlscsYBfqnYTA-bSYvCzqykb7LSBjLZiTbIlPyWP1nbK8Ozwn5Iv7y8_X3xsrz99uLp4d926jsnSwsCl5Nw7yQc69qzjHKgYRk1Hz0crlXRU9GpUQlHvrOPKA_Wc9Z0EaiWIU_JqP3eX4rcZcjFbzA6myQaIczZSKsq1kv8F2TBoJjSvYLcHXYo5J1ibXcKtTfeGUbP4MosMs8gwujN_fZmb2vbiMH8et-CPTQdBtf7yULfZ2WmdbHCYj5gQnZByWfN8j0E92h1CMtkhhHpjrCqK8RH_vccffpO2tA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16691392</pqid></control><display><type>article</type><title>Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Adams, Jill U. ; Chen, Xiaohong ; DeRiel, J. Kim ; Adler, Martin W. ; Liu-Chen, Lee-Yuan</creator><creatorcontrib>Adams, Jill U. ; Chen, Xiaohong ; DeRiel, J. Kim ; Adler, Martin W. ; Liu-Chen, Lee-Yuan</creatorcontrib><description>In vivo treatment with an antisense (AS) phosphorothioate oligodeoxynucleotide (oligo) to the rat κ-opioid receptor selectively inhibited κ-mediated analgesia in the rat cold-water tail-flick test. Intracerebroventricular (i.c.v.) AS oligo significantly inhibited the analgesic effect of i.c.v. spiradoline, but not that of μ- or δ-opioid agonists. The dose-effect curve for s.c. spiradoline was shifted to the right after AS, but not missense or sense oligo treatment. Thus, AS oligos provide another technique with which to selectively manipulate opioid receptors and further support the role of non-μ opioid receptors in mediating analgesia in rats.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/0006-8993(94)91723-X</identifier><identifier>PMID: 7895075</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Analgesia ; Animals ; Antisense ; Base Sequence ; Biological and medical sciences ; Injections, Intraventricular ; Male ; Medical sciences ; Molecular Sequence Data ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Oligodeoxynucleotide ; Oligonucleotides, Antisense - administration &amp; dosage ; Oligonucleotides, Antisense - genetics ; Oligonucleotides, Antisense - pharmacology ; Opioid ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Pyrrolidines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, kappa - antagonists &amp; inhibitors ; Spiradoline ; κ-opioid receptor</subject><ispartof>Brain research, 1994-12, Vol.667 (1), p.129-132</ispartof><rights>1994 Elsevier Science B.V. All rights reserved</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-e627722dc7260b51422e036b90bd2ba787c0358b8380dcac28de0d21547e0a7e3</citedby><cites>FETCH-LOGICAL-c417t-e627722dc7260b51422e036b90bd2ba787c0358b8380dcac28de0d21547e0a7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-8993(94)91723-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3343777$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7895075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adams, Jill U.</creatorcontrib><creatorcontrib>Chen, Xiaohong</creatorcontrib><creatorcontrib>DeRiel, J. Kim</creatorcontrib><creatorcontrib>Adler, Martin W.</creatorcontrib><creatorcontrib>Liu-Chen, Lee-Yuan</creatorcontrib><title>Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>In vivo treatment with an antisense (AS) phosphorothioate oligodeoxynucleotide (oligo) to the rat κ-opioid receptor selectively inhibited κ-mediated analgesia in the rat cold-water tail-flick test. Intracerebroventricular (i.c.v.) AS oligo significantly inhibited the analgesic effect of i.c.v. spiradoline, but not that of μ- or δ-opioid agonists. The dose-effect curve for s.c. spiradoline was shifted to the right after AS, but not missense or sense oligo treatment. Thus, AS oligos provide another technique with which to selectively manipulate opioid receptors and further support the role of non-μ opioid receptors in mediating analgesia in rats.</description><subject>Analgesia</subject><subject>Animals</subject><subject>Antisense</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Oligodeoxynucleotide</subject><subject>Oligonucleotides, Antisense - administration &amp; dosage</subject><subject>Oligonucleotides, Antisense - genetics</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Opioid</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrrolidines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Opioid, kappa - antagonists &amp; inhibitors</subject><subject>Spiradoline</subject><subject>κ-opioid receptor</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2KFDEQgIMo67j6Bgp9EFkPrfnp7iSXBVlWXVjworC3kE5qZkt6kjFJr-5L-EA-hM9k2hnmqBAIVfVVUdRHyHNG3zDKhreU0qFVWosz3b3WTHLR3jwgK6Ykbwfe0YdkdUQekyc5f62hEJqekBOpdE9lvyI_r0JJ1kGCMcU7qAG6ebKpKQls2dZE8x3LbWNDfQUzhAxNnHATPcQf92F2E8SCHpoSm9-_2rjDiL5J4GBXYsoNhlscsYBfqnYTA-bSYvCzqykb7LSBjLZiTbIlPyWP1nbK8Ozwn5Iv7y8_X3xsrz99uLp4d926jsnSwsCl5Nw7yQc69qzjHKgYRk1Hz0crlXRU9GpUQlHvrOPKA_Wc9Z0EaiWIU_JqP3eX4rcZcjFbzA6myQaIczZSKsq1kv8F2TBoJjSvYLcHXYo5J1ibXcKtTfeGUbP4MosMs8gwujN_fZmb2vbiMH8et-CPTQdBtf7yULfZ2WmdbHCYj5gQnZByWfN8j0E92h1CMtkhhHpjrCqK8RH_vccffpO2tA</recordid><startdate>19941219</startdate><enddate>19941219</enddate><creator>Adams, Jill U.</creator><creator>Chen, Xiaohong</creator><creator>DeRiel, J. Kim</creator><creator>Adler, Martin W.</creator><creator>Liu-Chen, Lee-Yuan</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19941219</creationdate><title>Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats</title><author>Adams, Jill U. ; Chen, Xiaohong ; DeRiel, J. Kim ; Adler, Martin W. ; Liu-Chen, Lee-Yuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-e627722dc7260b51422e036b90bd2ba787c0358b8380dcac28de0d21547e0a7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Analgesia</topic><topic>Animals</topic><topic>Antisense</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Oligodeoxynucleotide</topic><topic>Oligonucleotides, Antisense - administration &amp; dosage</topic><topic>Oligonucleotides, Antisense - genetics</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Opioid</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrrolidines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Opioid, kappa - antagonists &amp; inhibitors</topic><topic>Spiradoline</topic><topic>κ-opioid receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adams, Jill U.</creatorcontrib><creatorcontrib>Chen, Xiaohong</creatorcontrib><creatorcontrib>DeRiel, J. Kim</creatorcontrib><creatorcontrib>Adler, Martin W.</creatorcontrib><creatorcontrib>Liu-Chen, Lee-Yuan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adams, Jill U.</au><au>Chen, Xiaohong</au><au>DeRiel, J. Kim</au><au>Adler, Martin W.</au><au>Liu-Chen, Lee-Yuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1994-12-19</date><risdate>1994</risdate><volume>667</volume><issue>1</issue><spage>129</spage><epage>132</epage><pages>129-132</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>In vivo treatment with an antisense (AS) phosphorothioate oligodeoxynucleotide (oligo) to the rat κ-opioid receptor selectively inhibited κ-mediated analgesia in the rat cold-water tail-flick test. Intracerebroventricular (i.c.v.) AS oligo significantly inhibited the analgesic effect of i.c.v. spiradoline, but not that of μ- or δ-opioid agonists. The dose-effect curve for s.c. spiradoline was shifted to the right after AS, but not missense or sense oligo treatment. Thus, AS oligos provide another technique with which to selectively manipulate opioid receptors and further support the role of non-μ opioid receptors in mediating analgesia in rats.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>7895075</pmid><doi>10.1016/0006-8993(94)91723-X</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1994-12, Vol.667 (1), p.129-132
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_77802987
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Analgesia
Animals
Antisense
Base Sequence
Biological and medical sciences
Injections, Intraventricular
Male
Medical sciences
Molecular Sequence Data
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Oligodeoxynucleotide
Oligonucleotides, Antisense - administration & dosage
Oligonucleotides, Antisense - genetics
Oligonucleotides, Antisense - pharmacology
Opioid
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Pyrrolidines - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Opioid, kappa - antagonists & inhibitors
Spiradoline
κ-opioid receptor
title Intracerebroventricular treatment with an antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A04%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intracerebroventricular%20treatment%20with%20an%20antisense%20oligodeoxynucleotide%20to%20%CE%BA-opioid%20receptors%20inhibited%20%CE%BA-agonist-induced%20analgesia%20in%20rats&rft.jtitle=Brain%20research&rft.au=Adams,%20Jill%20U.&rft.date=1994-12-19&rft.volume=667&rft.issue=1&rft.spage=129&rft.epage=132&rft.pages=129-132&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/0006-8993(94)91723-X&rft_dat=%3Cproquest_cross%3E77802987%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16691392&rft_id=info:pmid/7895075&rft_els_id=000689939491723X&rfr_iscdi=true